SAC and Clinical Data

By using BeamMed™ MiniOmni™, we have conducted the Distal Radius Test Method, and to avoid experimental bias, we held the test three times. Moreover, we also used the Ultrasound BMD Tester to get more accurate results. Whilst women who are aged 55 years and older and have previously experienced post-menopause are at the highest risk for having Type I osteoporosis, we have investigated the BMD data for women who are aged 55 years and older after treating them with Sigma Anti-Boding Molecule Calcium Carbonate (SAC) for several months. The data below depict the difference in BMD after handling with SAC.